JPRN-UMIN000003346已完成未知
Plant sterol levels during cholesterol-lowering therapy - Plant sterol levels during cholesterol-lowering therapy
Kanazawa Medical University Department of Cardiology0 个研究点目标入组 100 人开始时间: 2010年3月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
In ezetimibe combination group, LDLC lowering respnoses were associated with the levels of cholesterol absorption markers before randomization. Contraly, those were associated with the level of cholesterol synthesis marker in atrovastatin doubling group.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Hypersenstivity Patient who has received it within four weeks undertaking administering of medicine Resin/Fibrate/Niacin/EPA/ Probucol etc Patient who judged that examination doctor in charge is improper
研究者
相似试验
已完成
早期 1 期
Phytosterols, Ezetimibe, and Cholesterol MetabolismCoronary Heart DiseaseHypercholesterolemiaNCT00863265Washington University School of Medicine22
已完成
4 期
LDL Receptor Under Ezetimibe and SimvastatinHealthy MenNCT00317993University of Cologne60
已完成
4 期
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.ST-Segment Elevation Myocardial InfarctionNCT01385631Odense University Hospital87
已完成
不适用
A study to evaluate the effect of ezetimibe and rosuvastatin on intravascular ultrasound-derived coronary atheroma and lipid lowering effect.dyslipidemiaJPRN-UMIN000010323Department of Cardiology and Nephrology, Mie University Graduate School of Medicine50
已完成
3 期
TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)HypercholesterolaemiaHyperlipidaemiaNCT00328523Organon and Co1,496